Drug Trial Radar · NCT00421863
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
Last checked: Nov 19, 2026Latest source record: Feb 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,111
Actual
Start
Feb 2005
Primary completion
Jan 2009
Study completion Jan 2009
Sponsor
- Lead sponsor
- Heart Care FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 15, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter, prospective, randomised, open study comparing the effect of the following two strategies in hypertensive subjects \> 55 years and poorly controlled (systolic blood pressure \>= 150 mmHg) by antihypertensive treatment: * usual strategy: reduction of systolic blood pressure to below 140 mmHg, independently of diastolic blood pressure levels; * intensive strategy: reduction of systolic blood pressure to below 130 mmHg, independently of diastolic blood pressure levels. During the initial run in period two qualifying visits at distance of 7-14 days will be carried out to establish whether blood pressure remains uncontrolled (systolic blood pressure \>=150 mmHg)by current drug treatment. At the end of the second visit eligible patients will be admitted to the study and the following examinations will be carried out: clinical visit, routine laboratory tests, 12-lead ECG. At this point eligible patients will be randomised to one of the two blood pressure goals outlined above. Subsequent clinical visits will be carried out at 4 month-intervals up to the end of the study (4, 8, 12, 16, 20, 24 months).
Conditions
- Hypertension
Interventions
Triatec 10 mgDrug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Triatec HCT 5Drug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Lasix 25Drug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Micardis 80 mgDrug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Micardis plus 80/12.5Drug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Catapresan TTS 2Drug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Norvasc 10 mgDrug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Triatec 5 mgDrug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
PluscorDrug
Use and dosage according to physician judgement, concomitant treatment assumed and randomization arm (Intensive Strategy vs. Usual Strategy).
Primary outcomes
What the sponsor says the trial is designed to measure.
- changes in Left Ventricular Hypertrophy (LVH) at Electro Cardio Gramme (ECG).Time frame: 0, 12, 24 months
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Ospedale Generale Regionale
Aosta, Italy
Azienda Ospedaliera G. Rummo
Benevento, Italy
Spedali Civili
Brescia, Italy
Azienda Ospedaliera G. Brotzu - S. Michele
Cagliari, Italy
Ospedale S. Elia
Caltanissetta, Italy
Ospedale Garibaldi-Nesima
Catania, Italy
Azienda Ospedaliera Mater Domini
Catanzaro, Italy
Ospedale Clinicizzato Santissima Annunziata
Chieti, Italy
Istituti Ospitalieri
Cremona, Italy
Dimi - Disem
Genova, Italy
Ospedale Generale Provinciale
Gorizia, Italy
Policlinico Universitario Federico II
Naples, Italy
Azienda Ospedaliera di Perugia
Perugia, Italy
Spedali Riuniti
Pistoia, Italy
Ospedale Civile
Ragusa, Italy
Ospedali Riuniti G. Melacrino F. Bianchi
Reggio Calabria, Italy
Ospedale San Filippo Neri
Roma, Italy
CTO
Roma, Italy
Ospedlae San Camillo
Roma, Italy
Ospedale San Camillo
Roma, Italy
Ospedale San Giovanni
Roma, Italy
Policlinico Universitario
Sassari, Italy
Azienda Ospedaliera
Syracuse, Italy
Azienda USL 4 Terni
Terni, Italy
Ospedale San Vito
Torino, Italy
Casa di Cura Villa Bianca
Trento, Italy
Ospedale Belcolle
Viterbo, Italy
Ospedale N. Melli
San Pietro Vernotico, Brindisi, Italy
Ospedale Civile Mellini
Chiari, BS, Italy
Ospedale Civile G. Chidichimo
Trebisacce, Cosenza, Italy
Istituto Neuromed
Pozzilli, Isernia, Italy
Presidio Ospedaliero F. Ferrari
Casarano, Lecce, Italy
Nuovo Ospedale Versilia
Lido di Camaiore, Lucca, Italy
Ospedale Civile
Castiglione del Lago, Perugia, Italy
Ospedale Civile Beato Giacomo Villa
Città della Pieve, Perugia, Italy
Presidio Ospedaliero Città di Castello
Città di Castello, Perugia, Italy
Ospedale Civile
Gubbio, Perugia, Italy
Presidio Ospedaliero
Todi, Perugia, Italy
Ospedale Silvestrini
Perugia, PG, Italy
Ospedale Civile
Sacile, Pordenone, Italy
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.